Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL
T-cell acute lymphoblastic leukemia (T-ALL) is a type of hematologic tumor with malignant proliferation of hematopoietic progenitor cells. However, traditional clinical treatment of T-ALL included chemotherapy...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Long Chen, Anqi Ren, Yuan Zhao, Hangyu Chen, Qifang Wu, Mengzhu Zheng, Zijian Zhang, Tongcun Zhang, Wu Zhong, Jian Lin and Haichuan Zhu Tags: Correspondence Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Arthritis | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Leukemia | Men | Rheumatoid Arthritis | Rheumatology